Dr. Nicholas S. Galanopoulos, MD

Dr. Galanopoulos practices at Hamilton Medical Center in Dalton, Georgia, part of Hamilton Health Care System.

Dr. Galanopoulos' NPI, 1922289347, was assigned on November 14, 2007. Dr. Galanopoulos graduated from University of Chicago, Pritzker School of Medicine in 2007. Dr. Galanopoulos holds Georgia license 82232.

Dr. Galanopoulos' primary practice is Hamilton Medical Center, at 1200 Memorial Drive, Dalton, GA 30720 in Whitfield County. The practice phone is (706) 272-6105.

Dr. Galanopoulos' primary practice is Hamilton Medical Center in Dalton, Georgia, part of Hamilton Health Care System. The medical group on file is Hamilton Medical Center. Dmand AI also links Dr. Galanopoulos to 1 more medical group, named with a free account. Dr. Galanopoulos' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galanopoulos practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Galanopoulos' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Galanopoulos' licenses on file in 2 states: Georgia and Illinois.

CMS data shows 1,605 Medicare services from Dr. Galanopoulos across 19 procedure codes in 2024, for 153 Medicare patients. Medicare paid $110,498 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Galanopoulos in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galanopoulos' median patient age at 72, with 53% women.

In 2024, Dr. Galanopoulos wrote 146 Medicare Part D claims for 56 patients. 88% of them were for generic drugs. CMS names the drug for 56 of them, across 2 drugs with 11 or more claims each, at $754 in total drug cost. In 2023, CMS named 75 claims across 4 drugs.

Dr. Galanopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 22 general payments to Dr. Galanopoulos from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. RaySearch Laboratories AB (publ) paid the most, $382.

Dr. Galanopoulos graduated from University of Chicago, Pritzker School of Medicine in 2007.